Verastem, Inc. Profile Avatar - Palmy Investing

Verastem, Inc.

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated prot…

Biotechnology
US, Needham [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Verastem, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Verastem, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Verastem, Inc..

End of VSTM's Analysis
CIK: 1526119 CUSIP: 92337C104 ISIN: US92337C2035 LEI: - UEI: -
Secondary Listings
VSTM has no secondary listings inside our databases.